CellSeed Inc.
Notice Regarding Monthly Exercise Status of the 25th Stock Acquisition Rights (with Exercise Price Adjustment Clause)
Published the monthly exercise status of the 25th stock acquisition rights (with exercise price adjustment clause). Number of shares granted in the target month: 66,700 shares; rights actually exercised: 667; exercise ratio against total issued 86,000 rights: 0.77%; unexercised shares at month-end: 37,266 shares. Share transfers on exercise occurred on multiple dates.
Key Figures
- Number of shares granted: 66,700 shares
- Number exercised: 667 rights
- Total issued: 86,000 rights
- Unexercised rights (end of previous month): 37,933 rights
- Unexercised rights (month-end): 37,266 rights
AI要約
Overview
CellSeed Inc. has published the monthly exercise status for September 2026 of the 25th stock acquisition rights (with exercise price adjustment clause) issued on December 8, 2025. The number of shares granted in the target month was 66,700 shares, and the number of rights actually exercised was 667, representing an exercise ratio of 0.77% against the total issued 86,000 rights. The number of unexercised shares at month-end decreased from 37,933 shares at the end of the previous month to 37,266 shares. Exercises were distributed across multiple dates from September 3 to September 30, with the largest number of exercises, 23,200 rights, confirmed on September 18.
Impact on Shareholders and Outlook
This report provides quantitative disclosure of exercise status and does not indicate any direct changes to capital policy for shareholders. Continuous monitoring of the remaining unexercised rights is necessary, and depending on future total issued numbers and market exercise trends, dilution effects may occur. For details, refer to past disclosed materials (the third-party allotment related information published in November 2025).
CellSeed Inc.
Company overview · Stock price · Financial data · All IR
